Inception Return
(12/12/2000)
|
8.13 %
|
|
YTD Return
|
2.88 %
|
|
NAVPS
(5/17/2024)
|
$41.60
|
|
Change
|
($0.06) / -0.14 %
|
|
|
Growth of $10,000
(As of April 30, 2024)
|
|
MER
|
1.22 %
|
|
Assets ($mil)
|
$683.43
|
|
Rank (1Yr)
|
143/171
|
|
Std Dev (3Yr)
|
13.53 %
|
|
Volatility Ranking (3Yr)
|
6/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
No Load
|
|
Max Front End
|
-
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
To obtain long-term capital appreciation by investing primarily in U.S. companies and global companies with U.S. operations or exposure to U.S. markets or whose securities are traded on a U.S. exchange, which are engaged in the design, development, manufacturing, and distribution of products or services in the health care sectors. The Fund will invest in a diversified portfolio, which will mainly include securities in the medical technology, biotechnology, health care, and pharmaceutical sectors
|
Fund Manager
CIBC Asset Management Inc.
Portfolio Manager
Michal Marszal, CIBC Asset Management Inc.
Sub-Advisor
Data not available
|
|
Asset Allocation
(As of April 30, 2024)
|
Sector Allocation
(As of April 30, 2024)
|
Geographic Allocation
(As of April 30, 2024)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Eli Lilly and Co | US Equity | Healthcare | United States | 8.04% |
| Roche Holding AG - Partcptn | International Equity | Healthcare | Other European | 7.01% |
| Novartis AG Cl N | International Equity | Healthcare | Other European | 6.51% |
| Thermo Fisher Scientific Inc | US Equity | Healthcare | United States | 6.32% |
| Medtronic PLC | International Equity | Healthcare | European Union | 6.29% |
| IQVIA Holdings Inc | US Equity | Healthcare | United States | 5.81% |
| UnitedHealth Group Inc | US Equity | Healthcare | United States | 5.51% |
| Johnson & Johnson | US Equity | Healthcare | United States | 5.02% |
| CVS Health Corp | US Equity | Healthcare | United States | 4.98% |
| Amgen Inc | US Equity | Healthcare | United States | 4.51% |
Performance Data
(As of April 30, 2024)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
-3.24
|
0.09
|
10.89
|
2.88
|
-1.66
|
2.21
|
5.69
|
8.79
|
|
Benchmark
|
-1.82
|
4.10
|
16.91
|
4.68
|
8.73
|
7.59
|
8.86
|
7.22
|
|
Quartile Ranking
|
2
|
4
|
4
|
3
|
4
|
3
|
3
|
4
|
|
Calendar Return (%)
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
|
Fund
|
-1.26
|
-5.40
|
9.83
|
10.77
|
18.16
|
8.31
|
6.70
|
-12.36
|
32.80
|
36.03
|
|
Benchmark
|
11.75
|
-5.84
|
25.09
|
5.60
|
22.88
|
-8.89
|
9.10
|
21.08
|
-8.32
|
10.55
|
|
Quartile Ranking
|
4
|
1
|
3
|
3
|
3
|
1
|
4
|
4
|
1
|
1
|